[go: up one dir, main page]

TR201819920T4 - Kuru göz sendromunun tedavisinde kullanım için oftalmik bileşimler. - Google Patents

Kuru göz sendromunun tedavisinde kullanım için oftalmik bileşimler. Download PDF

Info

Publication number
TR201819920T4
TR201819920T4 TR2018/19920T TR201819920T TR201819920T4 TR 201819920 T4 TR201819920 T4 TR 201819920T4 TR 2018/19920 T TR2018/19920 T TR 2018/19920T TR 201819920 T TR201819920 T TR 201819920T TR 201819920 T4 TR201819920 T4 TR 201819920T4
Authority
TR
Turkey
Prior art keywords
treatment
dry eye
eye syndrome
ophthalmic compositions
syndrome
Prior art date
Application number
TR2018/19920T
Other languages
English (en)
Inventor
Gelsomino Lucia
Original Assignee
Alfa Intes Ind Terapeutica Splendore S R L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alfa Intes Ind Terapeutica Splendore S R L filed Critical Alfa Intes Ind Terapeutica Splendore S R L
Publication of TR201819920T4 publication Critical patent/TR201819920T4/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Ophthalmology & Optometry (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Bu buluş, kuru göz sendromunun tedavisinde kullanım için yeni oftalmik farmasötik bileşimlere ilişkindir.
TR2018/19920T 2014-12-12 2015-12-11 Kuru göz sendromunun tedavisinde kullanım için oftalmik bileşimler. TR201819920T4 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI20142126 2014-12-12

Publications (1)

Publication Number Publication Date
TR201819920T4 true TR201819920T4 (tr) 2019-01-21

Family

ID=52463050

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2018/19920T TR201819920T4 (tr) 2014-12-12 2015-12-11 Kuru göz sendromunun tedavisinde kullanım için oftalmik bileşimler.

Country Status (7)

Country Link
EP (1) EP3229780B1 (tr)
DK (1) DK3229780T3 (tr)
ES (1) ES2712849T3 (tr)
PL (1) PL3229780T3 (tr)
PT (1) PT3229780T (tr)
TR (1) TR201819920T4 (tr)
WO (1) WO2016092513A1 (tr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11759472B2 (en) 2017-11-21 2023-09-19 Cs Pharmaceuticals Limited Compositions and methods of use for treating aberrant inflammation in peri-ocular secretory glands or at the ocular surface
KR102712798B1 (ko) * 2017-11-21 2024-10-04 씨에스 파마슈티컬스 리미티드 안구주위 분비선 또는 안구 표면에서의 이상 염증을 치료하기 위한 조성물 및 사용 방법
IT201900023142A1 (it) * 2019-12-05 2021-06-05 Sifi Spa Composizione topica oculare contenente metaboliti della fermentazione di lactobacillus

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1546469A (fr) 1965-09-07 1968-11-22 Merck & Co Inc Stérilisation de médicaments solides
GB1386864A (en) 1972-02-11 1975-03-12 Avicon Inc Micro-crystalline collage-containing pharmaceutical compositions useful for topical applications
JP2945993B2 (ja) * 1989-12-05 1999-09-06 武田薬品工業株式会社 外用剤
ITRM20010438A1 (it) 2001-07-23 2003-01-23 Farmigea Spa Preparato oftalmico a base di n-acetilcisteina per il trattamento della sindrome dell'occhio secco.
US20050196370A1 (en) 2003-03-18 2005-09-08 Zhi-Jian Yu Stable ophthalmic oil-in-water emulsions with sodium hyaluronate for alleviating dry eye
US20060148686A1 (en) 2004-12-30 2006-07-06 Bausch & Lomb Incorporated Ophthalmic compositions comprising steroid and cyclosporine for dry eye therapy

Also Published As

Publication number Publication date
ES2712849T3 (es) 2019-05-16
DK3229780T3 (en) 2019-03-18
PT3229780T (pt) 2019-02-27
PL3229780T3 (pl) 2019-05-31
EP3229780A1 (en) 2017-10-18
WO2016092513A1 (en) 2016-06-16
EP3229780B1 (en) 2018-11-28

Similar Documents

Publication Publication Date Title
EA201791460A1 (ru) N4-гидроксицитидин и связанные с ним производные и варианты противовирусного применения
BR112019006160A2 (pt) composições e métodos para o tratamento das condições oftálmicas
EA201790273A1 (ru) Флагеллиновые композиции и их применение
EA201691594A1 (ru) Циклопропиламины в качестве ингибиторов lsd1
EA201890204A1 (ru) Антибактериальные соединения
LT3882250T (lt) Tetrahidropiranilamino-pirolopirimidinonas, skirtas panaudoti btk nulemtų sutrikimų gydymui
HUE058737T2 (hu) Eljárások arenaviridae vírusok okozta fertõzések kezelésére
EA201691582A1 (ru) Новые фармацевтические препараты
EA201790630A1 (ru) Способы получения рибозидов
EA201692529A1 (ru) Способы и композиции для лечения расстройств с использованием фоллистатиновых полипептидов
LT3594238T (lt) Antikūno kompozicijos, skirtos navikų gydymui
BR112016030368A2 (pt) composição oftálmica
EA201790266A1 (ru) Индолы для применения при инфекции, вызванной вирусом гриппа
JO3564B1 (ar) ببتيدات وتركيبات لعلاج ضرر المفاصل
EA201692526A1 (ru) Замещенные [1,2,4]триазольные соединения
BR112017010177A2 (pt) composição para tratamento de tecido
EA201691429A1 (ru) МОДИФИЦИРОВАННЫЕ МЕНИНГОКОККОВЫЕ ПОЛИПЕПТИДЫ fHbp
EA201692552A1 (ru) МОДИФИЦИРОВАННЫЕ МЕНИНГОКОККОВЫЕ ПОЛИПЕПТИДЫ fHbp
MX377357B (es) Compuestos para dispositivos ópticamente activos.
CL2015002897A1 (es) Inhibidores de bace1
MX2016009590A (es) Composiciones de apilimod y métodos para usar las mismas.
EA201790655A1 (ru) Новые активаторы растворимой гуанилатциклазы и их применение
MX393092B (es) Bis-compuestos para dispositivos opticamente activos.
PL3978074T3 (pl) Terlipresyna do leczenia zespołu wątrobowo-nerkowego typu 1
MX381544B (es) Composición de células estromales mesenquimatosas para usare en el tratamiento de la sepsis en un sujeto.